Modulators of intracellular chloride concentration for treating neurodegenerative diseases with parkinsonian syndromes
AssigneesB&A Therapeutics, Centre Hospitalier Universitaire De Nantes, Inserm (Institut National De La Sante Et De La Recherche Medicale), Universite D'Aix-Marseille, Universite De Nantes
InventorsYehezkel BEN-ARI, Nathalie DEHORTER, Philippe DAMIER, Constance HAMMOND
Life of this patent
Estimating the term…
Abstract
A composition for treating Neurodegenerative Diseases with Parkinsonian Syndromes in a subject in need thereof, wherein the composition includes an effective amount of a modulator of a chloride transporter.
Claims16
1-13. (canceled)
A method for treating a neurodegenerative disease with Parkinsonian syndromes in a subject in need thereof, comprising administering an effective amount of a modulator of a chloride transporter, wherein said modulator is an inhibitor of a transporter involved in the importation of chloride into neurons.
Dependencies are inferred from the claim text.